A Study of Psilocybin for Major Depressive Disorder (MDD)

NCT03866174 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

347

Enrollment

OTHER

Sponsor class

Conditions

Depressive Disorder, Major

Interventions

DRUG: Psilocybin
DRUG: Niacin
OTHER: Set and Setting (SaS) Protocol

Sponsor

Usona Institute

Collaborators

[object Object]